Beyond Air Files 8-K: Other Events & Exhibits
Ticker: XAIR · Form: 8-K · Filed: Dec 3, 2024 · CIK: 1641631
| Field | Detail |
|---|---|
| Company | Beyond Air, Inc. (XAIR) |
| Form Type | 8-K |
| Filed Date | Dec 3, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, filing, corporate-actions
Related Tickers: XAIR
TL;DR
Beyond Air (XAIR) filed an 8-K on Dec 2, 2024, for other events and exhibits. Check for updates.
AI Summary
Beyond Air, Inc. filed an 8-K on December 3, 2024, reporting other events and financial statements/exhibits. The filing pertains to the period ending December 2, 2024. The company, formerly known as AIT Therapeutics, Inc. and KokiCare, Inc., is incorporated in Delaware and headquartered in Garden City, NY.
Why It Matters
This 8-K filing indicates that Beyond Air, Inc. is disclosing significant events or financial information beyond routine quarterly reports, which could impact investor understanding of the company's current status.
Risk Assessment
Risk Level: low — This filing is a standard 8-K for reporting events and exhibits, not indicating immediate financial distress or major strategic shifts.
Key Players & Entities
- Beyond Air, Inc. (company) — Registrant
- December 2, 2024 (date) — Earliest event reported date
- December 3, 2024 (date) — Filing date
- AIT Therapeutics, Inc. (company) — Former company name
- KokiCare, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Garden City, NY (location) — Principal executive office location
FAQ
What specific 'Other Events' are being reported by Beyond Air, Inc. in this 8-K?
The provided text does not detail the specific 'Other Events' reported, only that this item is included in the 8-K filing.
What financial statements and exhibits are included with this 8-K filing?
The filing indicates that 'Financial Statements and Exhibits' are included, but the specific contents are not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on December 2, 2024.
What is the principal executive office address for Beyond Air, Inc.?
The principal executive offices of Beyond Air, Inc. are located at 900 Stewart Avenue, Suite 301, Garden City, NY 11530.
What were the previous names of Beyond Air, Inc.?
Beyond Air, Inc. was formerly known as AIT Therapeutics, Inc. and KokiCare, Inc.
Filing Stats: 446 words · 2 min read · ~1 pages · Grade level 8.8 · Accepted 2024-12-03 16:05:14
Filing Documents
- form8-k.htm (8-K) — 36KB
- ex99-1.htm (EX-99.1) — 24KB
- 0001493152-24-048490.txt ( ) — 238KB
- xair-20241202.xsd (EX-101.SCH) — 3KB
- xair-20241202_lab.xml (EX-101.LAB) — 33KB
- xair-20241202_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BEYOND AIR, Inc. Date: December 3, 2024 By: /s/ Steven A. Lisi Name: Steven A. Lisi Title Chief Executive Officer